medigraphic.com
ISSN 0035-0052 (Print)

2021, Number 1

<< Back Next >>

Rev Mex Pediatr 2021; 88 (1)

Tuberous sclerosis: clinical and imaging findings in a series of Colombian pediatric patients

García-Martín D, Martínez-Córdoba N, Andrea-Cubides P, Espinosa-García ET, Araujo-Polaina AF

Language: Spanish
References: 31
Page: 10-17
PDF size: 262.39 Kb.


ABSTRACT

Introduction: Tuberous sclerosis complex (TSC) is an autosomal dominant disorder with multisystem involvement. In this disease, abnormalities are found in the skin, eye, central nervous system (CNS), kidney, heart, and lung. Objective: To describe the clinical characteristics of pediatric patients with TSC. Material and methods: Retrospective review of 12 patients diagnosed with TSC treated over a 10-year period (2010-2020) in a tertiary hospital in Bogotá, Colombia. Clinical and magnetic resonance imaging (MRI) data were recorded. Results: Seven patients were women. The mean age at diagnosis was 16 months. Only three patients had a history of a first-degree relative with the same condition. The 12 patients had dermatological alterations, 10/12 (83%) patients presented some type of cognitive-behavioral disorder, 7/12 with seizures, and 5/12 ophthalmological problems. In 11/12 patients, the MRI showed some abnormality, such as subependymal nodules and cortical dysplasia. Conclusions: The diagnosis of TSC is based on clinical criteria, mainly including neurological and dermatological disorders. In these patients, interdisciplinary management is required, since it is a multisystemic disease.


REFERENCES

  1. Lin DDM, Barker PB. Neuroimaging of phakomatoses. Semin Pediatr Neurol. 2006; 13(1): 48-62.

  2. Macías DM, Sánchez MN, Cebollero PM, Mandujano AG, Velázquez GG, Soto AV et al. Esclerosis tuberosa. Informe de un caso. Rev Española Patol. 2006; 39(4): 247-249.

  3. Wataya-Kaneda M, Tanaka M, Hamasaki T, Katayama I. Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 japanese patients. PLoS One. 2013; 8(5): 815-835.

  4. Wienecke R, Klemm E, Karparti S, Swanson NA, Green AJ, DeClue JE. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas. J Cutan Pathol. 2002; 29(5): 287-290.

  5. Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013; 49(4):243-54. doi: 10.1016/j.pediatrneurol.2013.08.001.

  6. Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015; 14(7): 733-745. Available from: http://dx.doi.org/10.1016/S1474-4422(15)00069-1

  7. Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB. A developmental and genetic classification for malformations of cortical development: Update 2012. Brain. 2012; 135(5): 1348-1369.

  8. Wataya-Kaneda M, Uemura M, Fujita K, Hirata H, Osuga K, Kagitani-Shimono K et al. Tuberous sclerosis complex: Recent advances in manifestations and therapy. Int J Urol. 2017; 24 (9): 681-691.

  9. Ga V, Barkovich J. The phakomatoses. Pediatr Neuroimaging. 2012; 5(2): 563-636.

  10. Pascual-Castroviejo I, Pascual-Pascual SI, Velázquez-Fragua R, Viaño J, Carceller F, Hernández-Moneo JL et al. Astrocitoma subependimario de células gigantes en el complejo de esclerosis tuberosa. Presentación de ocho pacientes infantiles. Neurologia. 2010; 25(5): 314-321.

  11. Guillén-Pinto D, Gonzales CV, Vidal W, Santivañez C, Vila J, Juárez T et al. Epilepsia en niños atendidos en el Hospital Nacional Cayetano Heredia de Lima, Perú, 2010-2016. Rev Neuropsiquiatr. 2019; 81(4): 217.

  12. Jankar tul N, B P, Palange, C V, Purandare. Tuberous sclerosis-A case report. Int J Biomed Res [Internet]. 2015; 6(06): 6. Available from: www.ssjournals.com

  13. Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet. 1996; 59(2): 400-406.

  14. Ebrahimi-Fakhari D, Meyer S, Vogt T, Pföhler C, Müller CSL. Dermatological manifestations of tuberous sclerosis complex (TSC). JDDG - J Ger Soc Dermatology. 2017; 15(7): 695-700.

  15. Alva M, Pinto M del pilar G, Daniel R, Olazabal IEQPC, Chocano ML, Isabel MQ de M. Esclerosis tuberosa: experiencia en pacientes pediátricos en el Hospital Nacional Cayetano Heredia/Tuberous sclerosis complex: experience in pediatric patients at the Hospital Nacional Cayetano Heredia. Diagnóstico. 2004; 43(5): 199-204.

  16. Peron A, Northrup H. Tuberous sclerosis complex. Am J Med Genet Part C Semin Med Genet. 2018; 178(3): 274-247.

  17. Randle SC. Tuberous sclerosis complex: a review. Pediatr Ann. 2017; 46 (4): 166-171.

  18. Kwiatkowski DJ. Tuberous sclerosis: from tubers to mTOR. Ann Hum Genet. 2003; 67(1): 87-96.

  19. Teng JMC, Cowen EW, Wataya-Kaneda M, Gosnell ES, Witman PM, Hebert AA et al. Dermatologic and dental aspects of the 2012 international tuberous sclerosis complex consensus statements. JAMA Dermatology. 2014; 150(10): 1095-1101.

  20. Houser OW, McLeod RA. Roentgenographic experience at the Mayo Clinic. In: Gomez MR, ed. Tuberous sclerosis. New York: Raven, 1979: 27-53.

  21. Nishio S, Morioka T, Suzuki S, Kira R, Mihara F, Fukui M. Subependymal giant cell astrocytoma: Clinical and neuroimaging features of four cases. J Clin Neurosci. 2001; 8(1): 31-34.

  22. Cheng TS. Tuberous sclerosis complex: an update. Hong Kong J Dermatology Venereol. 2012; 20(2): 61-67.

  23. Datta AN, Hahn CD, Sahin M. Clinical presentation and diagnosis of tuberous sclerosis complex in infancy. J Child Neurol. 2008; 23(3): 268-273.

  24. Jeste SS, Varcin KJ, Hellemann GS, Gulsrud AC, Bhatt R, Kasari C et al. Symptom profiles of autism spectrum disorder in tuberous sclerosis complex. Neurology. 2016; 87(8): 766-772.

  25. Pajak L, Jin F, Xiao GH, Soonpaa MH, Field LJ, Yeung RS. Sustained cardiomyocyte DNA synthesis in whole embryo cultures lacking the TSC2 gene product. Am J Physiol - Hear Circ Physiol. 1997; 273: 342-343.

  26. Salussolia CL, Klonowska K, Kwiatkowski DJ, Sahin M. Genetic etiologies, diagnosis, and treatment of tuberous sclerosis complex. Annu Rev Genomics Hum Genet. 2019; 20(1): 217-240.

  27. Karnak I, Alehan D, Ekinci S, Büyükpamukçu N. Cardiac rhabdomyoma as an unusual mediastinal mass in a newborn. Pediatr Surg Int. 2007; 23(8): 811-814.

  28. Chen KACLFD Bin. Tuberous sclerosis complex: renal imaging findings. Radiology. 2003; 225(2): 451-456.

  29. O'Callaghan FJ, Noakes MJ, Martyn CN, Osborne JP. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int. 2004; 94(6): 853-857.

  30. Rowley SA, O'Callaghan FJ, Osborne JP. Ophthalmic manifestations of tuberous sclerosis: A population based study. Br J Ophthalmol. 2001; 85(4): 420-423.

  31. Amin S, Kingswood JC, Bolton PF, Elmslie F, Gale DP, Harland C et al. The UK guidelines for management and surveillance of tuberous sclerosis complex. Oxford. 2019; 112(3): 171-182.




2020     |     www.medigraphic.com